Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Boston appeal against J&J award denied

This article was originally published in Clinica

Executive Summary

The US Supreme Court has declined to hear Boston Scientific's appeal over the $703m in damages it has to pay for infringing a Johnson & Johnson coronary stent patent. The news dealt another blow to Boston's stock value, which slipped a further 7% yesterday to close at $10.33 per share. On September 30, a US district court in Delaware awarded J&J $1.2bn in damages against Boston and Medtronic. Boston took the brunt of the damages, while Medtronic was ordered to pay the $521m. The ruling was a culmination of an eight-year court battle between the three companies over the Palmaz balloon expandable stent patent, which is owned by J&J.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT041052

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel